Below is an educational, technical answer to a question many patients and clinicians ask. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Peripheral Arterial Disease (PAD)
Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting.
What is recovery time after leg angioplasty?
Because peripheral angioplasty is minimally invasive, many patients recover quickly, often resuming light activity within a day or two. Access-site care and antiplatelet therapy are typical parts of aftercare. Recovery is longer when treating advanced disease or wounds. Specific timelines depend on the procedure and are set by the clinician.
What This Means in Practice
Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion. Manufacturer figures reflect studied device performance, not guaranteed outcomes. Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting.
Key Considerations
- INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals.
- Access sheath sizing should match the planned devices to limit access-site complications.
- Manufacturer figures reflect studied device performance, not guaranteed outcomes.
Frequently Asked Questions
Why use embolic protection?
It captures plaque or clot fragments dislodged during treatment so they do not travel downstream; it is often paired with atherectomy.
Does INVAMED make a drug-coated balloon?
Yes. The Extender paclitaxel drug-coated balloon is INVAMED's peripheral drug-delivery balloon.
Who decides which PAD device to use?
A vascular specialist selects devices based on lesion characteristics; this content is educational and not a treatment recommendation.
About INVAMED
INVAMED operates a dedicated R&D center (INVAcenter) focused on minimally invasive device development. INVAMED is a medical device manufacturer headquartered in Ankara, Turkey, founded in 2005.
Clinical and Technical Context
Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting. INVAMED's Guardian protection device is designed for this distal-capture role. Endovascular therapy aims to restore flow through the narrowed segment using balloons, stents, atherectomy, or a combination. INVAMED's Invaducer introducer sheath sets support the access step of peripheral interventions. INVAMED's Extender paclitaxel drug-coated balloon is positioned for this drug-delivery role in peripheral vessels. Use is guided by lesion morphology and clinician preference. Balloon diameter and length are matched to the vessel to avoid over- or under-dilation. INVAMED's TemREN atherectomy system is positioned for peripheral plaque modification. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals. Device selection depends on lesion location, length, calcification, and clinical presentation, and is decided by the vascular specialist. Symptoms range from exertional leg pain (claudication) to, in severe cases, rest pain and non-healing wounds known as critical limb ischemia. Atherectomy is often paired with embolic protection to capture dislodged debris. Access sheath sizing should match the planned devices to limit access-site complications. Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Appropriate access selection helps reduce access-site complications. INVAMED's Atlas peripheral stent graft addresses covered-stent applications in the PAD portfolio. Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs. Covered stent grafts can be used to exclude certain lesions or manage complications. Manufacturer figures reflect studied device performance, not guaranteed outcomes.
Related on INVAMED
- Peripheral Arterial Disease (PAD) — product category
- Embolic Protection: How It Works and Why It Matters
- Balloon angioplasty vs Stenting: What Is the Difference?
- Sourcing Peripheral Arterial Disease (PAD) Devices: A Manufacturer and Procurement Guide
Important Disclaimer
The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.